High intensity interval training (HIIT) may offer older adults a more efficient way to improve body composition. While many forms of exercise can reduce body fat, the intensity of the workout plays a critical role in preserving muscle mass as people age.
https://t.co/zmi5q42luS
We’ve gathered the world’s leading voices in metabolic and gastrointestinal science to create the ultimate roadmap for gut restoration.
SNEAK PEAK AT SOME OF THE LECTURERS:
Dr Pran Yoganathan (Gastroenterologist)
Dr. Nasha Winters, ND, FABNO
Dr @Sara C. Campbell, PhD
Dr @drjasonfung (nephrologist)
Dr. Robert Kiltz (Reproductive endocrinologist, obstetrician, and gynecologist)
Don't wait for the launch! Pre-order your Gut Health Training now to get early access and 30% savings - https://t.co/IOPVwbKcgU
#guthealth #guthealthforlife
Contribute to a student scholarship in honor of Dr. Sarah Hallberg--for research on diabetes prevention. This was her passion! And it remains so important. Dr. Sarah insisted on the word "reversal" to give hope to patients.
https://t.co/roG8pndpyG
Join us for a lecture today on cardiovascular risk assessment using coronary artery calcium scans, cardiac CT angiography and AI-enhanced modalities
Find out about the most impressive therapy of all for plaque progression: exercise
https://t.co/LbmZen5wXM
Why Are We Still Playing "Cholesterol Uno?" 🤔👇
(85 sec clip, link to full video below)
"When faced with data showing that “optimal” LDL-C levels fail to prevent atherosclerosis, the final retreat is almost always the same: the LDL-C just wasn’t low enough. “Lower is better” the mantra goes.
If a mean LDL of 57 mg/dL isn’t sufficient to make atherosclerosis an orphan disease, then the solution must be 40. Or 30. Or 20. Or even 10 mg/dL. Heck, let’s just try to hit zero like we’re playing cholesterol Uno…
What this reflexive response reveals is the profound keyhole thinking that has come to dominate conventional cardiology
Medicine has become so siloed and sub-specialized that success is often defined within the narrow boundaries of a single biomarker or organ system, rather than in terms of whole-person health.
It is entirely possible—at least in theory—that taking a sledgehammer to LDL-C and ApoB, driving them as close to zero as possible, could further reduce cardiovascular events.
But that framing dodges the far more important question: what are we trading? Because LDL-lowering therapies are not benign."
This is disturbing. I've purchased Kerrygold butter because I thought it was made from cows that only ate grass. It turns out that if a cow eats 1 blade of grass in its life the company can say the cow is grassfed. This was the basis of a lawsuit against Kerrygold.
The product needs to say 100% grass-fed to be sure the cow was always fed grass.
https://t.co/PsLL3w5bbK